CAS 1620758-31-7

Empagliflozin Impurity 55

CAS : 1620758-31-7

Formule : C₂₃H₂₇ClO₇

Couleur et forme : White To Off-White Solid

Masse moléculaire : 450.91

Ref: 4Z-E-6369

Empagliflozin Impurity 50 (Mixture of Diastereomers)

CAS : 1620758-31-7, 1620758-32-8

Formule : C₂₃H₂₇ClO₇

Couleur et forme : White To Off-White Solid

Masse moléculaire : 450.91

Ref: 4Z-E-6365

Empagliflozin R-Furanose

CAS : 1620758-31-7

Formule : C₂₃H₂₇ClO₇

Masse moléculaire : 450.91

Ref: ST-EA-CP-E7007

Empagliflozin R/S-Furanose

CAS : 1620758-31-7, 1620758-32-8

Applications Empagliflozin R/S-Furanose is a mixture of R and S isomers of Empagliflozin Furanose. Both are byproducts in the synthesis of Empagliflozin drug (E521510), which is potent and selective inhibitor of sodium glucose co-transporter-2 (SGLT-2).
References Thomas, L., et al.: Diabetes. Obesity. Metabol. 14, 94 (2012); Grempler, R., et al.: Diabetes. Obesity. Metabol., 14, 83 (2012); Wang, X., et al.: Org. Lett., 16, 4090 (2014);

Formule : C₂₃H₂₇ClO₇

Couleur et forme : White To Off-White

Masse moléculaire : 450.909

Ref: TR-E521560

Empagliflozin R-furanose

CAS : 1620758-31-7

Empagliflozin R-furanose is a drug product that belongs to the class of drugs for treatment of type II diabetes. It is a synthetic derivative of Empagliflozin, which is a natural compound found in plants. Empagliflozin R-furanose has been shown to inhibit the activity of dipeptidyl peptidase 4 (DPP-4) and reduce postprandial glucose levels in healthy subjects. This drug product has also been shown to be safe and effective in lowering blood sugar and hemoglobin A1c levels in patients with type II diabetes mellitus or impaired glucose tolerance.

Formule : C₂₃H₂₇ClO₇

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 450.91 g/mol

Ref: 3D-IE181147

1,4-Anhydro-1,5-dihydroxy-empagliflozin-d4

Produit contrôlé

CAS : 1620758-31-7, 1620758-32-8

Formule : C₂₃H₂₃D₄ClO₇

Couleur et forme : Neat

Masse moléculaire : 454.93

Ref: TR-A637897